Stage III Breast Cancer Terminated Phase 2 Trials for Vorinostat (DB02546)

IndicationStatusPhase
DBCOND0031775 (Stage III Breast Cancer)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01194427A Study of Vorinostat and Tamoxifen in Newly Diagnosed Breast CancerBasic Science